Erica Ollmann Saphire
#46,855
Most Influential Person Now
American structural biologist, immunologist and researcher
Erica Ollmann Saphire's AcademicInfluence.com Rankings
Erica Ollmann Saphirelaw Degrees
Law
#2825
World Rank
#3516
Historical Rank
#1218
USA Rank
Common Law
#156
World Rank
#169
Historical Rank
#23
USA Rank
Erica Ollmann Saphirebiology Degrees
Biology
#3038
World Rank
#4703
Historical Rank
#1283
USA Rank
Immunology
#349
World Rank
#362
Historical Rank
#78
USA Rank
Molecular Biology
#785
World Rank
#805
Historical Rank
#179
USA Rank
Download Badge
Law Biology
Erica Ollmann Saphire's Degrees
- PhD Molecular Biology University of California, San Diego
- Bachelors Biochemistry University of California, San Diego
Why Is Erica Ollmann Saphire Influential?
(Suggest an Edit or Addition)According to Wikipedia, Erica Ollmann Saphire is an American structural biologist and immunologist and a professor at the La Jolla Institute for Immunology. Her research investigates the structural biology of viruses that cause hemorrhagic fever such as Ebola, Sudan, Marburg, Bundibugyo, and Lassa. She was awarded the Presidential Early Career Award for Scientists and Engineers in 2008.
Erica Ollmann Saphire's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus (2020) (3171)
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection (2021) (1934)
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity (2020) (1215)
- Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design (2001) (875)
- Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41 (2001) (849)
- The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120 (2002) (700)
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor (2008) (664)
- Complement Is Activated by IgG Hexamers Assembled at the Cell Surface (2014) (553)
- Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling (2006) (421)
- Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120 (2003) (271)
- gp120: Biologic aspects of structural features. (2001) (266)
- Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression (2011) (237)
- Contrasting IgG structures reveal extreme asymmetry and flexibility. (2002) (233)
- Ebolavirus glycoprotein structure and mechanism of entry. (2009) (228)
- Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle (2013) (194)
- Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak (2016) (186)
- Structures of protective antibodies reveal sites of vulnerability on Ebola virus (2014) (175)
- Lassa Fever in Post-Conflict Sierra Leone (2014) (166)
- A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. (2018) (162)
- Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study (2021) (161)
- Immunological memory to SARS-CoV-2 assessed for up to eight months after infection (2020) (152)
- Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection (2016) (149)
- Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection (2018) (148)
- Structural basis for antibody-mediated neutralization of Lassa virus (2017) (144)
- Cathepsin Cleavage Potentiates the Ebola Virus Glycoprotein To Undergo a Subsequent Fusion-Relevant Conformational Change (2011) (138)
- The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold (2012) (131)
- Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits (2016) (128)
- Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression (2009) (127)
- Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus (2015) (124)
- Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection (2019) (124)
- A Shared Structural Solution for Neutralizing Ebolaviruses (2011) (121)
- Crystal structure of the Lassa virus nucleoprotein–RNA complex reveals a gating mechanism for RNA binding (2011) (117)
- A model for neutralization of viruses based on antibody coating of the virion surface. (2001) (117)
- Antibody-mediated protection against Ebola virus (2018) (112)
- Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex. (2015) (112)
- Structural Basis for Marburg Virus Neutralization by a Cross-Reactive Human Antibody (2015) (108)
- Molecular Features of the Broadly Neutralizing Immunoglobulin G1 b12 Required for Recognition of Human Immunodeficiency Virus Type 1 gp120 (2003) (103)
- Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae (2012) (97)
- A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses (2016) (94)
- SARS-CoV-2 infection generates tissue-localized immunological memory in humans (2021) (94)
- Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses (2015) (89)
- Structures of Ebola Virus GP and sGP in Complex with Therapeutic Antibodies (2016) (89)
- Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013 (2014) (88)
- Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies (2016) (86)
- Two-mAb cocktail protects macaques against the Makona variant of Ebola virus (2016) (80)
- Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site (2016) (75)
- Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism (2012) (73)
- Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA (2013) (71)
- Structural Basis for Differential Neutralization of Ebolaviruses (2012) (70)
- Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies. (2007) (67)
- The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12. (2003) (67)
- Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it. (2009) (65)
- Ebola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion (2011) (64)
- Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization (2020) (60)
- Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae (2013) (60)
- Crystal Structure of the Nipah Virus Phosphoprotein Tetramerization Domain (2013) (60)
- The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis (2016) (57)
- Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination (2021) (57)
- Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV (2016) (57)
- Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein (2018) (56)
- BROADLY NEUTRALIZING ANTIBODIES FROM HUMAN SURVIVORS TARGET A CONSERVED SITE IN THE EBOLA VIRUS GLYCOPROTEIN HR2/MPER REGION (2018) (56)
- A Vaccine against Ebola Virus (2020) (55)
- Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain. (2008) (55)
- mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions (2022) (53)
- Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names (2014) (53)
- Structural Basis for the dsRNA Specificity of the Lassa Virus NP Exonuclease (2012) (53)
- Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1. (2001) (52)
- gp41: HIV's shy protein (2004) (49)
- The brain ’ s functional network architecture reveals human motives (49)
- Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop. (2003) (48)
- Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus (2011) (46)
- Ebolavirus VP35 Coats the Backbone of Double-Stranded RNA for Interferon Antagonism (2013) (45)
- mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern (2022) (45)
- Crystal Structure of the Marburg Virus VP35 Oligomerization Domain (2016) (42)
- An efficient platform for screening expression and crystallization of glycoproteins produced in human cells (2009) (40)
- Ebola Virus VP 35 Protein Binds Double-Stranded RNA and Inhibits Alpha / Beta Interferon Production Induced by RIGI Signaling (2006) (39)
- Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. (2016) (39)
- Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design. (2003) (38)
- Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies. (2020) (38)
- Crystal Structure of Marburg Virus VP40 Reveals a Broad, Basic Patch for Matrix Assembly and a Requirement of the N-Terminal Domain for Immunosuppression (2015) (36)
- Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. (2015) (35)
- The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. (2018) (35)
- Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs (2015) (35)
- Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever (2018) (34)
- In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model (2018) (34)
- An update on the use of antibodies against the filoviruses. (2013) (33)
- Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses (2018) (32)
- Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination (2021) (32)
- An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. (2016) (31)
- Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope (2018) (31)
- Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein (2014) (31)
- Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization (2019) (30)
- Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2 (2020) (30)
- Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses (2012) (30)
- Stopping pandemics before they start: Lessons learned from SARS-CoV-2 (2022) (29)
- Development of Prototype Filovirus Recombinant Antigen Immunoassays. (2015) (29)
- Lassa virus glycoprotein: stopping a moving target (2018) (29)
- Two Synthetic Antibodies that Recognize and Neutralize Distinct Proteolytic Forms of the Ebola Virus Envelope Glycoprotein (2012) (28)
- The ebolavirus VP24 interferon antagonist (2012) (27)
- A cationic, C-terminal patch and structural rearrangements in Ebola virus matrix VP40 protein control its interactions with phosphatidylserine (2018) (26)
- Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein. (2009) (26)
- Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers (2020) (25)
- Structural Basis of Broad Ebolavirus Neutralization by a Human Survivor Antibody (2018) (24)
- Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk (2019) (22)
- Crystal Structure of the Oligomeric Form of Lassa Virus Matrix Protein Z (2016) (22)
- Filovirus Structural Biology: The Molecules in the Machine. (2017) (22)
- SnapShot: Enveloped Virus Entry (2020) (21)
- A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus. (2020) (19)
- Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein. (2017) (19)
- Achieving cross-reactivity with pan-ebolavirus antibodies. (2019) (18)
- Crystal Structure of Marburg Virus VP24 (2014) (18)
- Feverish Quest for Ebola Immunotherapy: Straight or Cocktail? (2016) (18)
- Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression. (2014) (18)
- Antibody therapy for Lassa fever. (2019) (17)
- Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses (2022) (17)
- Structure of a High-Affinity (2007) (17)
- Dhanier Ft Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp 41 (2009) (17)
- Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors (2018) (16)
- Structure-based design of a highly stable, covalently-linked SARS-CoV-2 spike trimer with improved structural properties and immunogenicity (2021) (16)
- The structural basis for filovirus neutralization by monoclonal antibodies. (2018) (16)
- Structural biology in the fight against COVID-19 (2021) (16)
- Structural Characterization of Pan-Ebolavirus Antibody 6D6 Targeting the Fusion Peptide of the Surface Glycoprotein (2018) (16)
- Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection (2019) (14)
- Cryo-EM structure of the Ebola virus nucleoprotein-RNA complex. (2019) (14)
- Ebola vaccine–induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects (2021) (13)
- Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles (2021) (13)
- Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination (2021) (12)
- Diverse Morphology and Structural Features of Old and New World Hantaviruses (2019) (12)
- Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages (2020) (12)
- Listening for viral infection (2001) (11)
- Structure of the Reston ebolavirus VP30 C-terminal domain (2014) (10)
- A Conserved Basic Patch and Central Kink in the Nipah Virus Phosphoprotein Multimerization Domain Are Essential for Polymerase Function. (2019) (10)
- Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry (2021) (9)
- Lifted Up from Lockdown (2020) (9)
- More than Meets the Eye: Hidden Structures in the Proteome. (2016) (8)
- Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody (2021) (8)
- Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries (2021) (8)
- Measles virus fusion shifts into gear (2011) (8)
- Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies (2022) (7)
- Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form (2021) (7)
- Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity (2022) (7)
- High-resolution Crystal Structure of Dimeric VP40 From Sudan ebolavirus. (2015) (7)
- Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors (2018) (7)
- A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera (2022) (6)
- Reporter Assays for Ebola Virus Nucleoprotein Oligomerization, Virion-Like Particle Budding, and Minigenome Activity Reveal the Importance of Nucleoprotein Amino Acid Position 111 (2018) (6)
- Role of Non-local Interactions between CDR Loops in Binding Affinity of MR78 Antibody to Marburg Virus Glycoprotein. (2017) (6)
- Structural Rearrangement of the Ebola Virus VP40 Protein Begets Multiple Functions in the Virus Life Cycle (2014) (5)
- Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization (2022) (5)
- Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment (2019) (5)
- A glimpse into immune responses evolving against Ebola virus (2019) (5)
- Potent Antibody Protection against an Emerging Alphavirus Threat (2015) (5)
- 133 Structural basis for ebolavirus matrix assembly and budding; protein plasticity allows multiple functions (2014) (5)
- CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN (2001) (5)
- Inducing broad-based immunity against viruses with pandemic potential. (2022) (4)
- CD164 is a host factor for lymphocytic choriomeningitis virus entry (2022) (4)
- Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma (2021) (4)
- Swift antibodies to counter emerging viruses (2015) (4)
- Glycan shield of the ebolavirus envelope glycoprotein GP (2022) (4)
- How to turn competitors into collaborators (2017) (4)
- Neutralizing Antibodies against Lassa Virus Lineage I (2022) (4)
- Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization (2021) (3)
- New Advances in the Effort against Ebola. (2015) (3)
- Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the Congo (2022) (3)
- Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae (2012) (3)
- Crystal structure of the trimeric prefusion Ebola virus glycoprotein in complex with a neutralizing antibody from a human survivor (2008) (3)
- Functional interactomes of the Ebola virus polymerase identified by proximity proteomics in the context of viral replication (2021) (3)
- Structure of an Ebola Virus-Protective Antibody in Complex with its Mucin-Domain Linear Epitope. (2012) (3)
- Asymmetric and Non-Stoichiometric Recognition Results in Broad Protection Against Ebolaviruses by a Two-Antibody Cocktail (2021) (2)
- Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA (2013) (2)
- Crystal Structure of a Broadly Neutralizing Anti-HIV-1 Antibody in Complex with a Peptide Mimotope (2004) (2)
- Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium (2023) (2)
- Visualization of intracellular Ebola virus nucleocapsid assembly by cryo-electron tomography (2021) (2)
- Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antivirals (2021) (2)
- Development and Structural Analysis of Antibody Therapeutics for Filoviruses (2022) (2)
- Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region (2018) (1)
- Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey (2022) (1)
- A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus (2022) (1)
- Structure of the Ebola virus nucleoprotein – RNA complex (2019) (1)
- Antibodies as drugs—a Keystone Symposia report (2022) (1)
- Enhanced IgG Hexamerization Mediates Efficient C1q Docking and Complement-Dependent Cytotoxicity; Preclinical Proof Of Concept On Primary CLL and Burkitt Lymphoma (2013) (1)
- Analysis of Oligomeric and Glycosylated Proteins by Size-Exclusion Chromatography Coupled with Multiangle Light Scattering. (2021) (1)
- IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern (2022) (1)
- E-105 Antibodies against ebola virus: Results of the viral hemorrhagic fever immunotherapeutic consortium (2016) (1)
- Systematic analysis of human antibody response to ebolavirus glycoprotein reveals high prevalence of neutralizing public clonotypes (2022) (1)
- Structure of BDBV GPcl in complex with the pan-ebolavirus mAb ADI-15878 (2018) (0)
- 1.8A crystal structure of Lassa virus nucleoprotein in complex with ssRNA (2012) (0)
- Spatial and functional arrangement of Ebola virus polymerase inside phase-separated viral factories (2022) (0)
- Structural basis for antibody-mediated neutralization of Lymphocytic choriomeningitis virus (2022) (0)
- IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE)) (2003) (0)
- A Manhattan Project against COVID (2022) (0)
- Crystal Structure of the Nipah Virus Phosphoprotein Multimerization Domain G519N (2019) (0)
- Crystal structure of the Lassa virus surface glycoprotein (2017) (0)
- 2.8A crystal structure of Lymphocytic Choriomeningitis Virus Nucleoprotein C-terminal Domain (2014) (0)
- Application Note Wyatt Technology Corporation Understanding Antibody and Viral Glycoprotein Interactions Using CG-MALS (2015) (0)
- Crystal structure of Reston ebolavirus VP35 RNA binding domain in complex with 18bp dsRNA (2010) (0)
- Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs (2015) (0)
- Cell Reports Resource In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model (0)
- The variety of study in the field of emerging viruses. (2012) (0)
- Crystal structure demonstrating CTD-CTD interactions of Zaire Ebola virus VP40 dimer (2020) (0)
- From Kenema to Our Krios: Medical Defense Against Lassa Virus and Emerging Infectious Disease (2020) (0)
- Crystal structure of Marburg virus VP35 RNA binding domain bound to 12-bp dsRNA (2012) (0)
- Structure of Lassa virus glycoprotein in complex with Fab 25.6A (2019) (0)
- Crystal structure of Marburg virus VP35 RNA binding domain (2012) (0)
- Exonuclease domain of Lassa virus nucleoprotein bound to manganese (2011) (0)
- Crystal Structure of Marburg virus VP40 Dimer (2016) (0)
- Ebola virus VP30 CTD bound to nucleoprotein (2016) (0)
- Analytical Validation of the ReEBOVAntigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection (2016) (0)
- Crystal structure of host-primed Ebola virus GP, GPcl. (2016) (0)
- Marburg virus VP30 bound to nucleoprotein (2016) (0)
- Ebola virus glycoprotein in complex with EBOV-520 Fab (2020) (0)
- Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013 (2013) (0)
- Ebola virus nucleoprotein bound to VP35 chaperoning peptide I212121 (2015) (0)
- Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae (2013) (0)
- Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report (2022) (0)
- Structure of Lassa virus glycoprotein bound to Fab 18.5C (2019) (0)
- EBOV GP in complex with variable Fab domains of IgGs c4G7 and c13C6 (2016) (0)
- Crystal structure of Reston ebolavirus VP35 RNA binding domain (2010) (0)
- Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk (2019) (0)
- Structural and functional analysis of cooperativity in a potent human antibody cocktail against Ebola virus (2020) (0)
- An emergent Ebola virus nucleoprotein variant influences virion budding, oligomerization, transcription and replication (2018) (0)
- Molecular assembly of measles and Nipah virus: specific lipid binding drives conformational change and matrix polymerization (2021) (0)
- Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence (2023) (0)
- Ebola virus VP40 octameric ring generated by a DNA oligonucleotide (2021) (0)
- Antibody-mediated protection against Ebola virus (2018) (0)
- Single Amino Acid Substitutions Dramatically Shift Equilibria of Physiologically Relevant Alternate Protein Assemblies (2019) (0)
- Coronavirus Immunotherapeutic Consortium Database (2023) (0)
- Crystal Structure of Ebola virus VP40 Hexamer (2013) (0)
- Therapeutic human monoclonal antibody MR191 bound to a marburgvirus glycoprotein (2018) (0)
- Plasmodium infection disrupts the T follicular helper cell response to heterologous immunization (2022) (0)
- Exonuclease domain of Lassa virus nucleoprotein (2011) (0)
- Crystal structure of Reston Ebola virus VP35 RNA binding domain bound to 12-bp dsRNA (2013) (0)
- Structure-based drug design. (2002) (0)
- 3A structure of Lassa virus nucleoprotein in complex with ssRNA (2012) (0)
- Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever (2018) (0)
- Structural transformation begets multiple functions in the viral life cycle (2018) (0)
- HISTORICAL NEWS AND VIEWS: gp41: HIV's shy protein (2004) (0)
- EBOV GP in complex with variable Fab domains of IgGs c2G4 and c13C6 (2016) (0)
- Crystal Structure of matrix protein VP40 from Ebola virus Sudan (2012) (0)
- Crystal Structure of an RNA-free VP40 Octameric Ring (2013) (0)
- Low resolution structure of Ebola virus M241R mutant (2013) (0)
- Cleaved Ebola GP in complex with a broadly neutralizing human antibody, ADI-15946 (2019) (0)
- A-002 Simple laboratory test results and mortality following coronary catheterization in Calgary , Alberta (2015) (0)
- Resilient Fc-Effector Functions Across SARS-CoV-2 Variants of Concern Following mRNA-1273 Vaccination (2021) (0)
- Mapping Epitopes of Pan‐Ebolavirus Antibodies From Human Survivors (2016) (0)
- Structure of the trimeric prefusion Ebola virus GP complexed with an antibody from a human survivor (2008) (0)
- The Ebola Virus Matrix Protein VP40 Interacts Selectively with Plasma Membrane Lipids to Promote Viral Egress (2017) (0)
- Crystal Structure of Dimeric Sudan Virus VP40 (2013) (0)
- Crystal structure of the 13F6-1-2 Fab fragment bound to its Ebola virus glycoprotein peptide epitope. (2008) (0)
- Determining the Patchwork Lattice of Ebola and Marburg Virus Matrix Layers Using Cryo-Electron Tomography (2021) (0)
- Crystal Structure of the Nipah Virus Phosphoprotein Multimerization Domain Delta 542-544 (2019) (0)
- 2.0A crystal structure of Lymphocytic Choriomeningitis Virus Nucleoprotein C-terminal Domain (2014) (0)
- Crystal structure of Marburg virus GP in complex with the human survivor antibody MR78 (2015) (0)
- Structure of the Inmazeb cocktail and resistance to Ebola virus escape. (2023) (0)
- Enhanced IgG hexamerization mediates efficient C1q docking and more rapid and substantial complement-dependent cytotoxicity; preclinical proof of concept (2014) (0)
- Structure of EBOV GPcl in complex with the pan-ebolavirus mAb ADI-15878 (2018) (0)
- Arenavirus monoclonal antibodies and uses (2017) (0)
- SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model (2023) (0)
- Novel attempts launched toward universal Sarbecovirus vaccine (2021) (0)
- Low resolution crystal structure of Zaire Ebola virus VP40 in space group P6422 (2020) (0)
- Lassa Fever in Post-Conflict Sierra Leone The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2014) (0)
- Anticorps monoclonaux de marburg (2015) (0)
- Antigen Binding Fragment of the Pan-ebolavirus Monoclonal Antibody 6D6 (2018) (0)
- EBOV sGP in complex with variable Fab domains of IgGs c13C6 and BDBV91 (2016) (0)
- Crystal structure of an unbound KZ52 neutralizing anti-Ebolavirus antibody. (2009) (0)
- Structural basis of broad ebolavirus neutralization by a human survivor antibody (2019) (0)
- A global consortium, next-generation SARS-CoV-2 antibody therapeutics and stabilized spike (2021) (0)
- Structure of the Inmazeb cocktail and resistance to escape against Ebola virus (2022) (0)
- Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates. (2023) (0)
- Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern (2021) (0)
- BDBV223 Fab bound to synthetic peptide of Bundibugyo virus Glycoprotein Stalk (2019) (0)
- Ebola Virology and Host/Virus Interaction (2015) (0)
- NON-NEUTRALIZING ANTIBODIES FROM A MARBURG INFECTION SURVIVOR MEDIATE PROTECTION BY INDUCTION OF STRONG FC-EFFECTOR FUNCTIONS AND ENHANCEMENT OF NEUTRALIZING EFFECTS OF OTHER ANTIBODIES, Philipp Ilinykh et al (2020) (0)
- Crystal structure of the prefusion glycoprotein of LCMV (2016) (0)
- Phosphoprotein Tetramerization Domain Crystal Structure of the Nipah Virus (2014) (0)
- Broad neutralization of SARS-CoV-2 variants by circular mRNA producing VFLIP-X spike in mice (2022) (0)
- Sudan virus nucleoprotein core domain in complex with VP35 chaperoning peptide (2019) (0)
- Assembly of the Ebola Viru s Nucleoprotein from a Chaperoned VP 35 Complex Graphical Abstract Highlights (2015) (0)
- Correction: The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold (2013) (0)
- Crystal structure of Sudan Ebolavirus Glycoprotein (strain Boniface) bound to 16F6 (2011) (0)
- Ebola virus VP40 octameric ring generated by an RNA oligonucleotide (0)
- Functional Studies of Ebola Virus Matrix Protein VP40 (2015) (0)
- SARS-CoV-2 antibodies specific to the mesa and inner side of spike protein receptor binding domain maintain high affinities for both D614G and b.1.351 variants (2022) (0)
- The Molecular Tool‐Kit of Viral Hemorrhagic Fevers (2015) (0)
- Ebola viral factories are biomolecular condensates with specialized assembly dynamics for viral RNA synthesis. (2023) (0)
This paper list is powered by the following services:
Other Resources About Erica Ollmann Saphire
What Schools Are Affiliated With Erica Ollmann Saphire?
Erica Ollmann Saphire is affiliated with the following schools:
